Savara Pharmaceuticals
SVRA
#6613
Rank
NZ$0.87 B
Marketcap
$5.08
Share price
-6.58%
Change (1 day)
-16.33%
Change (1 year)

Savara Pharmaceuticals (SVRA) - Cash on Hand

Cash on Hand as of June 2024 : NZ$0.20 Billion

According to Savara Pharmaceuticals's latest financial reports the company has NZ$0.20 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Savara Pharmaceuticals - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.25 B29.46%
2022-12-31NZ$0.19 B-15.98%
2021-12-31NZ$0.23 B107.15%
2020-12-31NZ$0.11 B-37%
2019-12-31NZ$0.18 B9.42%
2018-12-31NZ$0.16 B24.42%
2017-12-31NZ$0.13 B587.86%
2016-12-31NZ$19.3 M-67.76%
2015-12-31NZ$59.87 M-18.11%
2014-12-31NZ$73.11 M35.35%
2013-12-31NZ$54.02 M21.71%
2012-12-31NZ$44.38 M-31.68%
2011-12-31NZ$64.96 M79.14%
2010-12-31NZ$36.26 M203.91%
2009-12-31NZ$11.93 M-29.69%
2008-12-31NZ$16.97 M-61.15%
2007-12-31NZ$43.68 M-40.52%
2006-12-31NZ$73.44 M122.21%
2005-12-31NZ$33.05 M80.98%
2004-12-31NZ$18.26 M180.91%
2003-12-31NZ$6.5 M3174.03%
2002-12-31NZ$0.19 M-49.86%
2001-12-31NZ$0.39 M-88.17%
2000-12-31NZ$3.34 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$27.93 M-86.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$69.16 M-66.61%๐Ÿ‡บ๐Ÿ‡ธ USA